Spectacle Adherence Among Four-Year-Old Children in the Infant Aphakia Treatment Study.


Journal

American journal of ophthalmology
ISSN: 1879-1891
Titre abrégé: Am J Ophthalmol
Pays: United States
ID NLM: 0370500

Informations de publication

Date de publication:
04 2019
Historique:
received: 03 08 2018
revised: 28 12 2018
accepted: 29 12 2018
pubmed: 12 1 2019
medline: 18 12 2019
entrez: 12 1 2019
Statut: ppublish

Résumé

To evaluate spectacle adherence with impact-resistant lenses among 4-year-old children after unilateral cataract surgery in the Infant Aphakia Treatment Study. Retrospective cohort analysis of randomized clinical trial data. Setting: Multicenter. One hundred and fourteen children randomized to contact lens correction or intraocular lens implantation following unilateral cataract surgery during infancy. One-week diaries completed annually and retrospective telephone interviews conducted every 3 months to age 5 years to assess spectacle adherence with impact-resistant lenses. Visual acuity was assessed by a traveling examiner at age 4.5 years. Spectacle adherence between ages 4 and 5 years. Children with 20/40 or better vision in their treated eye were more likely to wear spectacles ≥80% of their waking hours than children with vision worse than 20/40 (66% vs 42%, P = .034). Reported adherence to spectacle wear correlated with reported patching (r = 0.30, P = .002). Spectacle adherence did not correlate with sex, type of healthcare insurance, or the refractive error in the treated or fellow eye. Seven patients with reduced vision in their treated eye reported <10% spectacle adherence. These results confirm that it is possible to achieve high levels of spectacle adherence among 4-year-old children after unilateral cataract surgery during infancy. However, children with vision worse than 20/40 in their worse eye, who needed eye protection the most, had the worst adherence.

Identifiants

pubmed: 30633891
pii: S0002-9394(19)30001-7
doi: 10.1016/j.ajo.2018.12.017
pmc: PMC6445735
mid: NIHMS1518155
pii:
doi:

Types de publication

Journal Article Multicenter Study Randomized Controlled Trial Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

26-33

Subventions

Organisme : NEI NIH HHS
ID : UG1 EY013287
Pays : United States
Organisme : NEI NIH HHS
ID : UG1 EY025553
Pays : United States
Organisme : NEI NIH HHS
ID : UG1 EY013272
Pays : United States
Organisme : NEI NIH HHS
ID : P30 EY026877
Pays : United States
Organisme : NEI NIH HHS
ID : U10 EY013272
Pays : United States
Organisme : NEI NIH HHS
ID : U10 EY013287
Pays : United States

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Références

Invest Ophthalmol Vis Sci. 2012 Jun 05;53(7):3368-75
pubmed: 22491410
Dev Med Child Neurol. 2016 Feb;58(2):154-9
pubmed: 26084944
Ophthalmic Plast Reconstr Surg. 2017 Jan/Feb;33(1):61-64
pubmed: 26866334
Arch Ophthalmol. 2010 Jan;128(1):21-7
pubmed: 20065212
Invest Ophthalmol Vis Sci. 1996 Jul;37(8):1532-8
pubmed: 8675395
Contemp Clin Trials Commun. 2016 Aug 15;3:158-166
pubmed: 27981259
Ophthalmology. 2017 Jun;124(6):822-827
pubmed: 28215452
Pediatrics. 1996 Aug;98(2 Pt 1):311-3
pubmed: 8692640
Pediatrics. 1987 Jul;80(1):13-7
pubmed: 3601512
Ophthalmologica. 2005 Mar-Apr;219(2):72-9
pubmed: 15802930
Am J Ophthalmol. 2001 Dec;132(6):903-9
pubmed: 11730656
Virtual Mentor. 2010 Dec 01;12(12):938-40
pubmed: 23186820
JAMA Ophthalmol. 2016 Dec 1;134(12):1347-1353
pubmed: 27737444
Invest Ophthalmol Vis Sci. 1993 Dec;34(13):3687-99
pubmed: 8258529
JAMA Ophthalmol. 2016 Aug 1;134(8):863-9
pubmed: 27228110
Lancet. 2002 Aug 24;360(9333):597-602
pubmed: 12241931
Ophthalmic Epidemiol. 2007 Jan-Feb;14(1):37-43
pubmed: 17365816
J Pediatr Ophthalmol Strabismus. 1993 Jul-Aug;30(4):249-52
pubmed: 8410576
Eye (Lond). 2016 Sep;30(9):1221-8
pubmed: 27472216
JAMA Ophthalmol. 2014 Jun;132(6):676-82
pubmed: 24604348
Am J Ophthalmol. 2015 Jan;159(1):64-70.e1-2
pubmed: 25261241
Arch Ophthalmol. 1992 Jun;110(6):838-42
pubmed: 1596232
Eye (Lond). 1998;12 ( Pt 2):173-8
pubmed: 9683933

Auteurs

Scott R Lambert (SR)

Department of Ophthalmology, Stanford University School of Medicine, Stanford, California, USA. Electronic address: Lambert7@stanford.edu.

Lindreth DuBois (L)

Department of Ophthalmology, Emory University, Atlanta, Georgia, USA.

George Cotsonis (G)

Department of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory University, Atlanta, Georgia, USA.

E Eugenie Hartmann (EE)

Department of Ophthalmology, Emory University, Atlanta, Georgia, USA.

Carolyn Drews-Botsch (C)

Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH